130 related articles for article (PubMed ID: 24649323)
1. Opposite variation tendencies of serum CA724 levels in patients with colon and rectal carcinoma.
Zhu Z; Chen Z; Chen C; Yang Z; Xuan W; Hou Y; Zuo Y; Ren S
Mol Clin Oncol; 2014 Jan; 2(1):139-145. PubMed ID: 24649323
[TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis.
Wang R; Zuo CL; Zhang R; Zhu LM
World J Gastrointest Oncol; 2023 Aug; 15(8):1475-1485. PubMed ID: 37663935
[TBL] [Abstract][Full Text] [Related]
3. Differences in carcinoembryonic antigen levels between colon and rectal cancer.
Ding Y; Xuan W; Chen C; Chen Z; Yang Z; Zuo Y; Ren S
Mol Clin Oncol; 2014 Jul; 2(4):618-622. PubMed ID: 24940506
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Serum CA242, CA724, and TPA Levels with Clinicopathological Features and Prognosis in Patients with Inflammatory Bowel Disease Complicated with Rectal Cancer.
Liang H; Yang X
J Oncol; 2022; 2022():7742760. PubMed ID: 36245974
[TBL] [Abstract][Full Text] [Related]
5. Decline of serum CA724 as a probable predictive factor for tumor response during chemotherapy of advanced gastric carcinoma.
Zou L; Qian J
Chin J Cancer Res; 2014 Aug; 26(4):404-9. PubMed ID: 25232212
[TBL] [Abstract][Full Text] [Related]
6. Increased serum CA724 levels in patients suffering gout vs cancers.
Zhang Y; Zhang M; Bai X; Li C; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():177-186. PubMed ID: 30905448
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
Bian J; Sun X; Li B; Ming L
Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
[TBL] [Abstract][Full Text] [Related]
8. Analysis of clinicopathological features and prognosis of 1315 cases in colorectal cancer located at different anatomical subsites.
Feng Z; Shi X; Zhang Q; Zhang X; Li X; Chen Z; Liu D; Sun B; Zuo Y; Ren S
Pathol Res Pract; 2019 Oct; 215(10):152560. PubMed ID: 31375274
[TBL] [Abstract][Full Text] [Related]
9. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy.
Tong Y; Zhao Y; Shan Z; Zhang J
BMC Cancer; 2021 Jan; 21(1):4. PubMed ID: 33402124
[TBL] [Abstract][Full Text] [Related]
10. CA724 is a novel factor for predicting the unresectability in pancreatic adenocarcinoma.
Liu P; Zhu Y; Liu L
Int J Clin Exp Pathol; 2015; 8(11):15112-7. PubMed ID: 26823852
[TBL] [Abstract][Full Text] [Related]
11. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.
Li F; Li S; Wei L; Liang X; Zhang H; Liu J
Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812
[TBL] [Abstract][Full Text] [Related]
12. Role of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer.
Peng Y; Zhai Z; Li Z; Wang L; Gu J
Int J Clin Exp Med; 2015; 8(1):982-90. PubMed ID: 25785084
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer.
Gong X; Zhang H
J Clin Lab Anal; 2020 Jul; 34(7):e23268. PubMed ID: 32118318
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential metabolite markers for colon cancer and rectal cancer using serum metabolomics.
Wu J; Wu M; Wu Q
J Clin Lab Anal; 2020 Aug; 34(8):e23333. PubMed ID: 32281150
[TBL] [Abstract][Full Text] [Related]
15. Study on the Differential Value of Tumor Marker CA724 on Primary Gastric Cancer.
Ding J; Zhang H; Wu Z
J Oncol; 2021; 2021():2929233. PubMed ID: 34608388
[TBL] [Abstract][Full Text] [Related]
16. A New Method for Early Screening of Gastric Cancer (G17 and CA724 Dual-Labeled Time-Resolved Fluorescence Immunoassay).
Liu C; Chen C; Lai H; Liang H; Zhong S; Guo G; Wang L; Li L
Comput Math Methods Med; 2022; 2022():1704948. PubMed ID: 35912162
[TBL] [Abstract][Full Text] [Related]
17. [Application of serum tumor markers and support vector machine in the diagnosis of oral squamous cell carcinoma].
Zhong LP; Zhou XJ; Wei KJ; Yang X; Ma CY; Zhang CP; Zhang ZY
Shanghai Kou Qiang Yi Xue; 2008 Oct; 17(5):457-60. PubMed ID: 18989582
[TBL] [Abstract][Full Text] [Related]
18. Biological variation of serum neuron-specific enolase and carbohydrate antigen 724 tumor markers.
Wang S; Zhao M; Mu R; Zhang X; Yun K; Shang H
J Clin Lab Anal; 2018 May; 32(4):e22327. PubMed ID: 28926140
[TBL] [Abstract][Full Text] [Related]
19. Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.
Zhuang PY; Zhu MJ; Wang JD; Zhou XP; Quan ZW; Shen J
J Dig Dis; 2013 Jan; 14(1):45-50. PubMed ID: 23134201
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer].
Han ZH; Chen JJ; Feng N; Niu PF; Song C; Gao ZY; Gao QK; Ji DB; Wang WB; Lei FM; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):966-971. PubMed ID: 31630495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
